Leesa Gentry
Chief Clinical Officer · RenovoRx, Inc.
Individual
- 2025
- Apr 8, 2026
- 2
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Leesa Gentry files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Ramtin Agah - $56K in RNXT purchases and sales in the last 12 months
- Mark Voll - $20K in RNXT purchases and sales in the last 12 months
- Shaun Bagai - $9K in RNXT purchases and sales in the last 12 months
- Laurence Marton - RNXT
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Leesa Gentry?
Leesa Gentry is a corporate insider, tracked as Chief Clinical Officer of RenovoRx, Inc. (RNXT). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Leesa Gentry last file a Form 4?
The most recent primary Form 4 on record is dated 8 April 2026, one of 2 filings going back to 2025.